Home 2018-07-18T12:14:50+00:00


At M4K Pharma, we are using open science to revolutionize how affordable new treatments are discovered and developed. Through our Medicines4Kids program, we will aggregate and align the work of global academics, foundations and industry researchers to advance new cures for childhood diseases not well-served by current business models.

M4K Pharma’s Data:
In line with M4K Pharma’s open science principles, we are committed to sharing our research data freely in the public domain. Our data is currently available for public viewing in the video recordings of our monthly open scientific updates, which are posted to our Blog and also available through our YouTube Channel. Data will be openly available in a downloadable format soon.

Missed our November Scientific Update meeting? Listen to a recording of the meeting's discussions here: https://t.co/4aA1tcBv9O


Ros Adamson @thesgconline refines her structures of the #DIPG and #FOP target ALK2/ACVR1 in complex with chemical inhibitors from @M4KPharma. https://t.co/LSGC1HWHBZ @DefeatDIPG @FOPFriends

Ellie Williams @thesgconline investigates how a mutation in the Alk2 gene leads to #FOP, a rare genetic disease with no cure. #Openscience notebook: https://t.co/3IdBio1RlJ Blog: https://t.co/DeeIO6lBoP @FOPFriends

REMINDER: M4K's Scientific Team Update Meeting is TOMORROW. Be a part of open source drug discovery to #defeatDIPG. Everyone is welcome! Wednesday November 7th (10:00am-12:00pm EST) on Zoom at:
https://t.co/eIejGEhS8p #OpenScience

Load More...

Latest Blog Posts